Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest Dune Medical Devices Stories

2013-02-28 08:29:47

BOSTON, Feb. 28, 2013 /PRNewswire/ -- Dune Medical Devices announced today that the MarginProbe System will be used at the Breast Center, Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Hospital, in Munich, Germany. The Breast Center treats over 400 primary breast cancer cases annually at its two sites Maistrasse-Innenstadt and Grosshadern. "We are excited to get started with the MarginProbe System. With currently available techniques, positive margins are a...

2012-09-27 02:27:10

FRAMINGHAM, Mass., Sept. 27, 2012 /PRNewswire/ -- Dune Medical Devices announced today that the MarginProbe System will be used at the Agaplesion Markus Hospital, in Frankfurt, Germany. The Agaplesion Markus Hospital is the largest breast center in the Frankfurt area, treating over 400 primary breast cancer cases annually. "In my previous work with the MarginProbe System, we saw a significant reduction in the number of patients who had to come back for additional surgeries due to positive...

2012-09-17 02:25:36

FRAMINGHAM, Mass., Sept. 17, 2012 /PRNewswire/ -- Dune Medical Devices announced today results of a study published in the journal Nature.com demonstrating the utility of the MarginProbe technology in prostate cancer surgery. The prototype device, developed by Dune Medical, was designed to enable use of Dune's patented radiofrequency spectroscopy technology in radical prostatectomy procedures, to aid surgeons in complete removal of the prostate gland while achieving negative surgical...

2012-06-22 02:22:19

GAITHERSBURG, Md., June 22, 2012 /PRNewswire/ -- Dune Medical Devices announced today that a U.S. Food and Drug Administration (FDA) Advisory Panel voted (10 to 1) in favor of Dune's MarginProbe System for use in breast cancer surgery, as an adjunct to current standard methods of intraoperative surgical margin assessment. Dune submitted a Premarket Application (PMA) in April 2011 based on data from a 600 patient pivotal study conducted primarily in the U.S. "We are very pleased...

2012-03-22 02:25:01

VIENNA, March 22, 2012 /PRNewswire/ -- Dune Medical Devices, the manufacturer of the MarginProbe(®) System, held a satellite symposium featuring discussions with experts in the field of breast cancer regarding the treatment of women with early stage breast cancer and the importance of margin assessment in breast conserving surgery. The panel conducted a thorough review of clinical experience with the MarginProbe System, designed to improve a surgeon's ability to identify the presence of...

2012-01-10 07:00:00

FRAMINGHAM, Mass., Jan. 10, 2012 /PRNewswire/ -- Dune Medical Devices announced today the appointment of Dr. Alberto Costa to the position of Chief Medical Advisor for Dune Medical Devices Europe. Costa is internationally renowned as an expert in breast cancer care, and widely known for innovative ideas in educational development in his role as Director of the European School of Oncology. A specialized breast surgeon at Professor Veronesi's school in Milan, Costa is Executive Director...

2011-12-08 17:00:00

FRAMINGHAM, Mass., Dec. 8, 2011 /PRNewswire/ -- An analysis of the MarginProbe pivotal study for patients with ductal carcinoma in situ (DCIS) and invasive lobular carcinoma (ILC) were presented today during the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. The results were presented by Dr. Susan K. Boolbol, Chief, Division of Breast Surgery, Beth Israel Medical Center, New York, New York. In patients with DCIS or ILC, adjunctive use of MarginProbe significantly improved...

2011-11-30 07:00:00

FRAMINGHAM, Mass., Nov. 30, 2011 /PRNewswire/ -- A clinical study to be published in the upcoming issue of the journal "The Breast", describes the use of Dune Medical's MarginProbe System as an adjunct to the standard of care in lumpectomy surgeries of women with early stage ductal carcinoma in situ of the breast. The research team, led by Marc Thill, M.D., Ph.D, Head of Gynecological Cancer Center and Head of Breast Center, Department of Gynecology and Obstetrics, University...

2011-11-28 08:00:00

FRAMINGHAM, Mass., Nov. 28, 2011 /PRNewswire/ -- The German Ministry of Health has published a new and unique procedure code for Dune Medical's MarginProbe System, which becomes effective on January 1, 2012. Use of this procedure code is the first step in securing reimbursement for new medical technologies from the German Ministry of Health and will facilitate determination of cost effectiveness and cost benefit of the MarginProbe System, currently in use at a number of breast...

2010-01-12 07:00:00

NEW YORK, Jan. 12 /PRNewswire/ -- Dune Medical Devices today announced the completion of patient enrollment in the MarginProbe(TM) pivotal clinical trial. The MarginProbe procedure provides surgeons with real-time detection of cancer at the edges of the tissue removed during breast conservation surgery (BCS), which is the only way to ensure the complete removal of the tumor from the breast. The randomized, controlled trial includes 664 women who underwent BCS at one of 21 leading medical...